Deep-tech: 19 successful projects
GENELPIS
Generic therapy for neurological disorders’treatment
CEO: Philippe Chambon, MD, PhD
Creation: may 2019
Headcount: 4
Location: Paris
Market(s): Treatment of neurological disorders
-
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
| Name | Provider | Purpose | Expiry | Type |
|---|---|---|---|---|
| viewed_cookie_policy | GDPR Cookie Consent | Is the primary cookie that records the user consent for the usage of the cookies upon accept and reject. | 1 year | HTTP Cookie |
| cookielawinfo-checkbox-non-necessary | GDPR Cookie Consent | Records the default button state of the corresponding category. It works only in coordination with the primary cookie. | 1 year | HTTP Cookie |
| mediaplanBAK et mediaplan | satt-paris-saclay.fr | Server cookies used for load balancing and website security. | session | HTTP Cookie |
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
| Name | Provider | Purpose | Expiry | Type |
|---|---|---|---|---|
| _ga | satt-paris-saclay.fr | Registers a unique ID that is used to generate statistical data on how the visitor uses the website. | 2 years | HTTP Cookie |
| _gat | satt-paris-saclay.fr | Used by Google Analytics to throttle request rate | 1 day | HTTP Cookie |
| _gid | satt-paris-saclay.fr | Registers a unique ID that is used to generate statistical data on how the visitor uses the website. | 1 day | HTTP Cookie |